XNYS
NHI
Market cap3.13bUSD
Oct 08, Last price
64.58USD
1D
0.97%
1Q
-14.27%
Jan 2017
-12.93%
Name
National Health Investors Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1991, National Health Investors, Inc. (NYSE: NHI) operates as a real estate investment trust (REIT) primarily focused on providing capital for senior living and medical real estate assets. The company facilitates this through diverse financing options, including sale-leaseback arrangements, joint ventures, and various debt instruments such as mortgage and mezzanine loans, targeting properties that cater to both essential care needs and discretionary services. NHI's broad holdings feature independent living, assisted living, and memory care facilities, as well as entrance-fee retirement communities, skilled nursing homes, medical office complexes, and specialized hospitals.
Key people
W. Andrew Adams
Independent Chairman of the Board · since 2011
D. Eric Mendelsohn
President, Chief Executive Officer · since 2015
John L. Spaid
Chief Financial Officer, Executive Vice President - Finance · since 2019
David L. Travis
Senior Vice President, Chief Accounting Officer · since 2020
Kevin Carlton Pascoe
Chief Investment Officer · since 2017
Kristin S. Gaines
Chief Credit Officer · since 2010
James R. Jobe
Independent Director · since 2013
Robert T. Webb
Independent Director · since 1991
Legal address
C/O NATIONAL REGISTERED AGENTS, INC. OF MD
2405 YORK ROAD
SUITE 201
LUTHERVILLE TIMONIUM, MD 21093-2264
US
2405 YORK ROAD
SUITE 201
LUTHERVILLE TIMONIUM, MD 21093-2264
US
Headquarters
11 EAST CHASE STREET
BALTIMORE, MD 21202
US
BALTIMORE, MD 21202
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||